Lonidamine
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Also known as: diclondazolic acid, doridamina
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Lonidamine is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including Mpc2, MPC2 and MPC1L. Recorded indications include Malignant tumor of lung.
- Molecular targets: Mpc2, MPC2 and MPC1L (3 listed in DrugCentral).
- Indications: Malignant tumor of lung.
- ATC code: L01XX07 (Other antineoplastic agents).
- Molecular formula: C15H10Cl2N2O2; molecular weight 321.16 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Malignant tumor of lung
Mechanism & targets
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Mitochondrial pyruvate carrier 2 | Mpc2 | inhibitor | IC50 5.60 |
| Mitochondrial pyruvate carrier 2 | MPC2 | inhibitor | IC50 5.34 |
| Mitochondrial pyruvate carrier 1-like protein | MPC1L | inhibitor | IC50 5.34 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
L01XX07 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › OTHER ANTINEOPLASTIC AGENTS › Other antineoplastic agents |
Chemical structure
| Molecular formula | C15H10Cl2N2O2 |
|---|---|
| Molecular weight | 321.16 g/mol |
| CAS number | 50264-69-2 |
| InChIKey | WDRYRZXSPDWGEB-UHFFFAOYSA-N |
| PubChem CID | 39562 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Lonidamine used for?
DrugCentral lists the following indications for Lonidamine: Malignant tumor of lung.
How does Lonidamine work?
Its molecular targets in DrugCentral include Mpc2 (inhibitor), MPC2 (inhibitor) and MPC1L (inhibitor).
What is the chemical formula of Lonidamine?
Lonidamine has the molecular formula C15H10Cl2N2O2 and a molecular weight of 321.16 g/mol.
Browse: all drugs starting with L · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1598 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1257030 — compound record and bioactivity
- PubChem CID 39562 — chemical identifiers
- DrugBank DB06266 — drug record
- FDA UNII U78804BIDR — substance identity
- UniProt O95563 (MPC2) — target protein
- UniProt P0DKB6 (MPC1L) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.